Abstract
Patients with symptomatic esophageal cancer represent a significant challenge to the thoracic clinician, whether medical oncologist, surgeon, or radiation therapist. Historically, cure has been rare and palliation has been a more realistic goal. Surgery was often viewed as radical or risky as limited long-term survival was weighed against expected operative morbidity and mortality. Epidermoid tumors were minimally responsive to available chemotherapy. Primary radiotherapy achieved similar overall survival; however, recurrent dysphagia limited its palliative benefit.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 216S-217S |
| Journal | Chest |
| Volume | 107 |
| Issue number | 6 SUPPL. |
| DOIs | |
| State | Published - Jan 1 1995 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
Fingerprint Dive into the research topics of 'A neoadjuvant approach to esophageal cancer'. Together they form a unique fingerprint.
Cite this
DeCamp, M. M., & Sugarbaker, D. J. (1995). A neoadjuvant approach to esophageal cancer. Chest, 107(6 SUPPL.), 216S-217S. https://doi.org/10.1378/chest.107.6_Supplement.216S